The Biogenesis of Chylomicrons, Annual Review of Physiology, vol.72, issue.1, pp.315-333, 2010. ,
DOI : 10.1146/annurev-physiol-021909-135801
The mechanism of the formation and secretion of chylomicrons, Atherosclerosis Supplements, vol.11, issue.1, pp.11-16, 2010. ,
DOI : 10.1016/j.atherosclerosissup.2010.03.003
Microsomal triglyceride transfer protein, the abetalipoproteinemia gene product, mediates the secretion of apolipoprotein B-containing lipoproteins from heterologous cells, J Biol Chem, vol.269, pp.21951-21954, 1994. ,
Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia, Atherosclerosis, vol.206, issue.1, pp.193-198, 2009. ,
DOI : 10.1016/j.atherosclerosis.2009.01.037
Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia, Science, vol.258, issue.5084, pp.999-1001, 1992. ,
DOI : 10.1126/science.1439810
Cloning and gene defects in microsomal triglyceride transfer protein associated with
abetalipoproteinaemia, Nature, vol.365, issue.6441, pp.65-69, 1993. ,
DOI : 10.1038/365065a0
The intracellular transport of chylomicrons requires the small GTPase, Sar1b, Current Opinion in Lipidology, vol.15, issue.2, pp.191-197, 2004. ,
DOI : 10.1097/00041433-200404000-00012
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders, Nature Genetics, vol.34, issue.1, pp.29-31, 2003. ,
DOI : 10.1038/ng1145
COPII: A membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum, Cell, vol.77, issue.6, pp.895-907, 1994. ,
DOI : 10.1016/0092-8674(94)90138-4
COPII-Coated Vesicle Formation Reconstituted with Purified Coat Proteins and Chemically Defined Liposomes, Cell, vol.93, issue.2, pp.263-275, 1998. ,
DOI : 10.1016/S0092-8674(00)81577-9
URL : http://doi.org/10.1016/s0092-8674(00)81577-9
Anderson or chylomicron retention disease: Molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein, Molecular Genetics and Metabolism, vol.93, issue.1, pp.74-84, 2008. ,
DOI : 10.1016/j.ymgme.2007.08.120
Three ways to make a vesicle, Nature Reviews Molecular Cell Biology, vol.1, issue.3, pp.187-198, 2000. ,
DOI : 10.1038/35043117
COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle, Journal of Cell Science, vol.116, issue.2, pp.415-427, 2003. ,
DOI : 10.1242/jcs.00215
Vesicle-associated membrane protein 7 is expressed in intestinal ER, Journal of Cell Science, vol.119, issue.5, pp.943-950, 2006. ,
DOI : 10.1242/jcs.02803
Anderson???s disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities, Clinical Genetics, vol.16, issue.3, pp.546-552, 2008. ,
DOI : 10.1111/j.1399-0004.2008.01069.x
Novel Missense Mutations of SAR1B Gene in an Infant With Chylomicron Retention Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.48, issue.3, pp.370-373, 2009. ,
DOI : 10.1097/MPG.0b013e318183188f
Unusual causes of steatorrhoea in infancy and childhood, Med J Aust, vol.48, issue.2, pp.617-622, 1961. ,
Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease., Journal of Clinical Investigation, vol.78, issue.2, pp.398-410, 1986. ,
DOI : 10.1172/JCI112590
Anderson's Disease : Exclusion of Apolipoprotein and Intracellular Lipid Transport Genes, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.10, pp.2494-2508, 1999. ,
DOI : 10.1161/01.ATV.19.10.2494
Action tremor as a manifestation of chylomicron retention disease, Annals of Neurology, vol.64, issue.5, p.591, 1983. ,
DOI : 10.1002/ana.410140517
[Anderson's disease. Clinical and morphologic study of 7 cases], Arch Fr Pediatr, vol.46, pp.491-498, 1989. ,
Studies on lipoprotein metabolism in a family with jejunal chylomicron retention, European Journal of Clinical Investigation, vol.28, issue.4, pp.271-280, 1995. ,
DOI : 10.1007/BF02535122
Chylomicron retention disease: exclusion of apolipoprotein B gene defects and detection of mRNA editing in an affected family, Atherosclerosis, vol.108, issue.2, pp.201-207, 1994. ,
DOI : 10.1016/0021-9150(94)90115-5
Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families., Journal of Clinical Investigation, vol.87, issue.1, pp.367-370, 1991. ,
DOI : 10.1172/JCI114996
Cathelineau L: [Anderson's disease], Ann Pediatr, vol.17, pp.342-354, 1970. ,
[Idiopathic disorder of intestinal fat transport (Anderson's disease). A further case], Arch Fr Pediatr, vol.30, pp.564-565, 1973. ,
Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B, Gastroenterology, vol.92, issue.2, pp.390-399, 1987. ,
DOI : 10.1016/0016-5085(87)90133-8
Hypobetalipoproteinaemia--a variant of the Bassen-Kornzweig syndrome., Gut, vol.20, issue.2, pp.163-168, 1979. ,
DOI : 10.1136/gut.20.2.163
Anderson??s Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.16, issue.3, pp.257-264, 1993. ,
DOI : 10.1097/00005176-199304000-00006
Chylomicron retention disease: A long term study of two cohorts, Molecular Genetics and Metabolism, vol.97, issue.2, pp.136-142, 2009. ,
DOI : 10.1016/j.ymgme.2009.02.003
Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B, European Journal of Gastroenterology & Hepatology, vol.21, issue.1, pp.104-108, 2009. ,
DOI : 10.1097/MEG.0b013e3282ffd9f8
Persistence of the intestinal defect in abetalipoproteinaemia after liver transplantation, European Journal of Pediatrics, vol.157, issue.7, pp.576-578, 1998. ,
DOI : 10.1007/s004310050882
Liver ultrastructure in abetalipoproteinemia: Evolution of micronodular cirrhosis, Gastroenterology, vol.67, pp.107-118, 1974. ,
The neurologic syndrome of vitamin E deficiency: A significant cause of ataxia, Neurology, vol.43, issue.11, pp.2167-2169, 1993. ,
DOI : 10.1212/WNL.43.11.2167
Vitamin E and neurologic deficits, Adv Pediatr, vol.37, pp.119-148, 1990. ,
VLDL exits from the endoplasmic reticulum in a specialized vesicle, the VLDL transport vesicle, in rat primary hepatocytes, Biochemical Journal, vol.413, issue.2, pp.333-342, 2008. ,
DOI : 10.1042/BJ20071469
Apo B100-containing lipoproteins are secreted by the heart., Journal of Clinical Investigation, vol.101, issue.6, pp.1197-1202, 1998. ,
DOI : 10.1172/JCI1785
Genes for apolipoprotein B and microsomal triglyceride transfer protein are ,
http://www.ojrd.com/content/5/1/24 expressed in the heart: evidence that the heart has the capacity to synthesize and secrete lipoproteins, Orphanet Journal of Rare Diseases Circulation, vol.5, issue.98, pp.2413-2429, 1998. ,
Plasma Cholesterol and Triglyceride Distributions in 13,665 Children and Adolescents: the Prevalence Study of the Lipid Research Clinics Program, Pediatric Research, vol.14, issue.3, pp.194-202, 1980. ,
DOI : 10.1203/00006450-198003000-00004
Variable phenotypic expression of chylomicron retention disease in a kindred carrying a mutation of the Sara2 gene, Metabolism, vol.59, issue.4, pp.463-467, 2010. ,
DOI : 10.1016/j.metabol.2009.07.042
Analysis of dual energy X-ray absorptiometry whole body results in children, adolescents and young adults, Applied Radiation and Isotopes, vol.49, issue.5-6, pp.623-624, 1998. ,
DOI : 10.1016/S0969-8043(97)00195-4
Pediatric Dual-Energy X-ray Absorptiometry: Technique, Interpretation, and Clinical Applications, Seminars in Nuclear Medicine, vol.37, issue.4, pp.303-313, 2007. ,
DOI : 10.1053/j.semnuclmed.2007.02.007
Ataxia with isolated vitamin E deficiency: A clinical, biochemical and genetic diagnosis, Journal of Paediatrics and Child Health, vol.36, issue.5, pp.515-516, 2000. ,
DOI : 10.1046/j.1440-1754.2000.00534.x
ABETALIPOPROTEINEMIA TREATED WITH PARENTERAL AND ORAL VITAMINS A AND E, AND WITH MEDIUM CHAIN TRIGLYCERIDES, Acta Paediatrica, vol.48, issue.6, pp.796-801, 1978. ,
DOI : 10.1016/S0014-4835(64)80055-5
Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein., Journal of Clinical Investigation, vol.67, issue.5, pp.1441-1450, 1981. ,
DOI : 10.1172/JCI110173
The neuropathy of abetalipoproteinemia, Neurology, vol.30, issue.12, pp.1286-1291, 1980. ,
DOI : 10.1212/WNL.30.12.1286
A-??-lipoproteinemia, Journal of Clinical Gastroenterology, vol.26, issue.3, pp.207-211, 1998. ,
DOI : 10.1097/00004836-199804000-00012
A double-blind trial of vitamin E in angina pectoris, Am J Clin Nutr, vol.27, pp.1174-1178, 1974. ,
Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study, Neurology, vol.50, issue.6, pp.1900-1902, 1998. ,
DOI : 10.1212/WNL.50.6.1900
Bioavailability of a Novel, Water-Soluble Vitamin E Formulation in Malabsorbing Patients, Digestive Diseases and Sciences, vol.49, issue.5 Pt 1, pp.347-352, 2007. ,
DOI : 10.1007/s10620-006-9489-2
Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis, Journal of Clinical Pharmacy and Therapeutics, vol.104, issue.5, pp.515-522, 2009. ,
DOI : 10.1111/j.1365-2710.2009.01027.x
The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption, Journal of Inherited Metabolic Disease, vol.41, issue.S1, pp.88-92, 1985. ,
DOI : 10.1007/BF01800666
Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans, J Lipid Res, vol.34, pp.343-358, 1993. ,
Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers, Orphanet Journal of Rare Diseases, vol.5, issue.1, p.24, 2010. ,
DOI : 10.1186/1750-1172-5-24
URL : https://hal.archives-ouvertes.fr/inserm-00654377